Jiaoyan Qiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jiaoyan Qiu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yu Zhang
School of Civil Engineering, Shandong University, Jinan 250061, China
3 shared publications - Lin Han
Institute of Marine Science and Technology Shandong University Qingdao China
2 shared publications - Yuzhen Huang
Institute of Marine Science and Technology, Shandong University, Qingdao 266237, China
2 shared publications Kai Zhang
1 shared publicationLiang Tao
Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong Province, China
1 shared publicationLin Han
1 shared publication
Latest Publications
- Open Access
- 17 March 2026
- Published by Wolters Kluwer Health in Advanced Technology in Neuroscience
Nanomaterials integrated with multiple technologies increase the diagnostic efficacy of biomarkers for neurological diseases: A narrative review
Nanomaterials have attracted attention in the field of neurological diseases due to the advantages of diversity, modifiability, biocompatibility, chemical stability, and thermal stability. This article reviews the mechanisms and properties of various nanomaterials, including quantum dots, magnetic nanoparticles, metallic nanoparticles, carbon-based nanomaterials, polymer nanoparticles, and nanocomposites. It also elucidates the research and application progress in biomarker detection for neurological diseases and bioimaging in the field of neural repair. In the field of neurobiomarker detection, nanomaterials can integrate multiple technical approaches to achieve highly sensitive and rapid biomarker detection, which significantly enhances experimental efficiency and the reliability of experimental results. In the fields of bioimaging and neural repair, nanomaterials can be combined with fluorescent molecules to accelerate the real-time localization of lesions, improving their diagnostic and therapeutic efficacy. In addition, the use of nanomaterials integrated with tissue engineering scaffolds offer a novel approach for neural repair. At present, the diagnosis and treatment of neurological diseases are gradually shifting from a single-modal paradigm to a multi-modal paradigm. This shift reflects the evolution of diagnostic detection methods from single detection methods to integrated multiple detection techniques. Artificial intelligence technologies have also been introduced for screening effective targets. When combined with nanomaterials, these technologies can enhance the efficacy of neurological disease diagnosis and treatment.
- 17 March 2026
- Published by Wolters Kluwer Health in Advanced Technology in Neuroscience
Open AccessNanomaterials integrated with multiple technologies increase the diagnostic efficacy of biomarkers for neurological diseases: A narrative review
Nanomaterials have attracted attention in the field of neurological diseases due to the advantages of diversity, modifiability, biocompatibility, chemical stability, and thermal stability. This article reviews the mechanisms and properties of various nanomaterials, including quantum dots, magnetic nanoparticles, metallic nanoparticles, carbon-based nanomaterials, polymer nanoparticles, and nanocomposites. It also elucidates the research and application progress in biomarker detection for neurological diseases and bioimaging in the field of neural repair. In the field of neurobiomarker detection, nanomaterials can integrate multiple technical approaches to achieve highly sensitive and rapid biomarker detection, which significantly enhances experimental efficiency and the reliability of experimental results. In the fields of bioimaging and neural repair, nanomaterials can be combined with fluorescent molecules to accelerate the real-time localization of lesions, improving their diagnostic and therapeutic efficacy. In addition, the use of nanomaterials integrated with tissue engineering scaffolds offer a novel approach for neural repair. At present, the diagnosis and treatment of neurological diseases are gradually shifting from a single-modal paradigm to a multi-modal paradigm. This shift reflects the evolution of diagnostic detection methods from single detection methods to integrated multiple detection techniques. Artificial intelligence technologies have also been introduced for screening effective targets. When combined with nanomaterials, these technologies can enhance the efficacy of neurological disease diagnosis and treatment.
- 25 September 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 475
Enhanced dual-mode electrochemical zinc ion sensing by electric field-driven bi-directional mass transport
- 25 September 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 475
Enhanced dual-mode electrochemical zinc ion sensing by electric field-driven bi-directional mass transport
- Open Access
- 8 March 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (18) , e202104054
Rapid and High‐Throughput SARS‐CoV‐2 RNA Detection without RNA Extraction and Amplification by Using a Microfluidic Biochip
The ongoing outbreak of the severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) has spread globally and poses a threat to public health and National economic development. Rapid and high‐throughput SARS‐CoV‐2 RNA detection without the need of RNA extraction and amplification remain a key challenge. In this study, a new SARS‐CoV‐2 RNA detection strategy using a microfluidic biochip for the rapid and ultrasensitive detection of SARS‐CoV‐2 without RNA extraction and amplification was developed. This new strategy takes advantage of the specific SARS‐CoV‐2 RNA and probe DNA reaction in the microfluidic channel, fluorescence signal regulation by nanomaterials, and accurate sample control by the microfluidic chip. It presents an ultralow limit of detection of 600 copies mL−1 in a large linear detection regime from 1 aM to 100 fM. Fifteen samples were simultaneously detected in 40 min without the need for RNA purification and amplification. The detection accuracy of the strategy was validated through quantitative reverse transcription polymerase chain reaction (qRT‐PCR), with a recovery of 99–113 %. Therefore, the SARS‐CoV‐2 RNA detection strategy proposed in this study can potentially be used for the quantitative diagnosis of viral infectious diseases.
- 8 March 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (18) , e202104054
Open AccessRapid and High‐Throughput SARS‐CoV‐2 RNA Detection without RNA Extraction and Amplification by Using a Microfluidic Biochip
The ongoing outbreak of the severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) has spread globally and poses a threat to public health and National economic development. Rapid and high‐throughput SARS‐CoV‐2 RNA detection without the need of RNA extraction and amplification remain a key challenge. In this study, a new SARS‐CoV‐2 RNA detection strategy using a microfluidic biochip for the rapid and ultrasensitive detection of SARS‐CoV‐2 without RNA extraction and amplification was developed. This new strategy takes advantage of the specific SARS‐CoV‐2 RNA and probe DNA reaction in the microfluidic channel, fluorescence signal regulation by nanomaterials, and accurate sample control by the microfluidic chip. It presents an ultralow limit of detection of 600 copies mL−1 in a large linear detection regime from 1 aM to 100 fM. Fifteen samples were simultaneously detected in 40 min without the need for RNA purification and amplification. The detection accuracy of the strategy was validated through quantitative reverse transcription polymerase chain reaction (qRT‐PCR), with a recovery of 99–113 %. Therefore, the SARS‐CoV‐2 RNA detection strategy proposed in this study can potentially be used for the quantitative diagnosis of viral infectious diseases.